Soni Medicare Closes Trading Window Ahead of Q4 FY26 Results

As routine compliance ahead of financial reporting, Soni Medicare Ltd. has announced a closure of its trading window for Directors, Officers, Designated Persons, and their immediate relatives. This mandatory step aligns with SEBI's directives aimed at preventing insider trading.

The window will commence on April 1, 2026, and will reopen 48 hours after the company declares its audited financial results for the quarter and fiscal year ended March 31, 2026.

This prohibition is critical to prevent individuals with access to unpublished price-sensitive information (UPSI) from trading in the company's securities. It ensures a level playing field for all investors and maintains market integrity as crucial financial performance data is set to be disclosed.

Company Background and Financial Performance

Soni Medicare Ltd., an India-based company, operates Soni Hospital in Jaipur, offering superspecialist and general hospital services. The company, incorporated in 1988, provides a range of healthcare services. However, recent financial reports indicate ongoing challenges. For the quarter ended December 2025, the company reported a net loss of Rs 1.13 crore. Sales also saw a significant decline, falling by 28.72% to Rs 5.36 crore in the same quarter compared to the previous year. Furthermore, Soni Medicare has reported negative Return on Equity (ROE) for at least three consecutive years ending FY25.

Restrictions and Risks

During the trading window closure, Directors, designated employees, and their relatives are prohibited from buying or selling Soni Medicare shares. Adherence to these SEBI norms is crucial, as failure to comply can lead to regulatory scrutiny and penalties. Given the recent net losses and negative ROE, the company faces increased attention on all its compliance aspects.

Industry Context

Soni Medicare operates within the Hospitals & Diagnostic Centres sector. Major competitors like Apollo Hospitals Enterprise Ltd., Max Healthcare Institute Ltd., and Fortis Healthcare Ltd. also implement similar trading window closures as per SEBI guidelines to uphold fair trading practices.

What to Watch Next

Investors will await a separate intimation regarding the date of the Board Meeting, which will consider and approve the audited financial results for the quarter and year ended March 31, 2026. The public announcement of these Q4 FY26 results will mark the reopening of Soni Medicare's trading window.